Evodiamine
SIAL/Y0001908 - European Pharmacopoeia (EP) Reference Standard
CAS Number: 518-17-2
Empirical Formula (Hill Notation): C19H17N3O
Molecular Weight: 303.36
MDL Number: MFCD06407824
Linear Formula: C19H17N3O
Product Type: Chemical
API family | evodiamine |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C19H17N3O/c1-21-16-9-5 |
InChI key | TXDUTHBFYKGSAH-SFHVURJKSA |
manufacturer/tradename | EDQM |
SMILES string | [H][C@@]1(N(C)C2=C3C=CC=C |
storage temp. | 2-8°C |
Application: | Evodiamine EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia. |
Biochem/physiol Actions: | Evodiamine is an indole alkaloid found in Evodia rutaescarpa. It acts as an anti-inflammatory compound; the mechanism of action may be inhibition of prostaglandin E2 synthesis or by cyclooxygenase 2 induction and NF-κB activation. Evodiamine has been studied for multiple cellular effects, including apoptotic activity, interference with metastasis and inhibition of angiogenesis. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Packaging: | The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue . |
Symbol | GHS07 |
Signal word | Warning |
Hazard statements | H302 |
Precautionary statements | P301 + P312 + P330 |
RIDADR | UN 2811 6.1 / PGII |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | 2-8°C |
UNSPSC | 12352116 |